ConductScience.org, home

Paper96735

Relationship between gentamicin susceptiblity criteria and therapeutic serum levels for Pseudomonas aeruginosa in mouse infection model.

Nicas TI and 1 other. Antimicrob Agents Chemother, 1978. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Relationship between gentamicin susceptiblity criteria and therapeutic serum levels for Pseudomonas aeruginosa in mouse infection model. Papers, record 96735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/96735

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Relationship between gentamicin susceptiblity criteria and therapeutic serum levels for Pseudomonas aeruginosa in mouse infection model.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.27
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nicas TIT I
2Bryan LEL E

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GentamicinsMajor topic
Pseudomonas InfectionsMajor topic
Animals
Cyclophosphamide
Male
Mice
Mice, Inbred ICR
Microbial Sensitivity Tests
Pseudomonas aeruginosa

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11159333Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years (1935-1972), with special reference to hospital-acquired cases.J Infect Dis1975https://conductscience.org/library/papers/1159333PubMed
21103724Prospective comparative study of variable dosage and variable frequency regimens for administration of gentamicin.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/1103724PubMed
315828182Butirosin compared with gentamicin in vitro and in vivo.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/15828182PubMed
4169729Activity of gentamicin, tobramycin, polymyxin B, and colistimethate in mouse protection tests with Pseudomonas aeruginosa.Antimicrob Agents Chemother1975https://conductscience.org/library/papers/169729PubMed
54196445Activity of aminoglycoside antibiotics aganst Pseudomonas aeruginosa: specificity and site of calcium and magnesium antagonism.J Infect Dis1973https://conductscience.org/library/papers/4196445PubMed
64209069Dissociation between results of in vitro and in vivo antibiotic susceptibility tests for some strains of Pseudomonas aeruginosa.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4209069PubMed
74306972Recent microbiological studies with gentamicin.J Infect Dis1969https://conductscience.org/library/papers/4306972PubMed
84370727Antibiotic susceptibility testing of Pseudomonas aeruginosa: selection of a control strain and criteria for magnesium and calcium content in media.J Infect Dis1974https://conductscience.org/library/papers/4370727PubMed
94791309Enzymatic acetylation as a means of determining serum aminoglycoside concentrations.Antimicrob Agents Chemother1973https://conductscience.org/library/papers/4791309PubMed
104983355Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.J Clin Pathol1969https://conductscience.org/library/papers/4983355PubMed
115001619Microbiologic studies related to bacterial resistance to gentamicin.J Infect Dis1971https://conductscience.org/library/papers/5001619PubMed
125001620Pseudomonas bacteremia: pharmacologic and other bases for failure of treatment with gentamicin.J Infect Dis1971https://conductscience.org/library/papers/5001620PubMed
135001629Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin.J Infect Dis1971https://conductscience.org/library/papers/5001629PubMed
14804983Further properties of P-2 R-factors of Pseudomonas aeruginosa and their relationship to other plasmid groups.Can J Microbiol1975https://conductscience.org/library/papers/804983PubMed
15816976Therapy of neutropenic rats infected with Pseudomonas aeruginosa.J Infect Dis1976https://conductscience.org/library/papers/816976PubMed
16818897Pseudomonas bacteremia. Review of 108 cases.Am J Med1976https://conductscience.org/library/papers/818897PubMed
17820641Effect of cyclophosphamide on the immune response to Pseudomonas aeruginosa in mice.Infect Immun1976https://conductscience.org/library/papers/820641PubMed
18821904Gentamicin resistance in clinical-isolates of Pseudomonas aeruginosa associated with diminished gentamicin accumulation and no detectable enzymatic modification.J Antibiot (Tokyo)1976https://conductscience.org/library/papers/821904PubMed
19903671Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin.J Infect Dis1977https://conductscience.org/library/papers/903671PubMed
20143238Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/143238PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
40024488Nanogels conjugated with cell-penetrating peptide as drug delivery vehicle for treating urinary tract infections.Nanomedicine2025https://conductscience.org/library/papers/40024488PubMed
38877321A 'rich-get-richer' mechanism drives patchy dynamics and resistance evolution in antibiotic-treated bacteria.Mol Syst Biol2024https://conductscience.org/library/papers/38877321PubMed
23047527The inoculum effect and band-pass bacterial response to periodic antibiotic treatment.Mol Syst Biol2012https://conductscience.org/library/papers/23047527PubMed
6794444Involvement of the outer membrane in gentamicin and streptomycin uptake and killing in Pseudomonas aeruginosa.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6794444PubMed
3475033Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3475033PubMed
2508542Determinants of the efficacy of tobramycin therapy against isogenic nonmucoid and mucoid derivatives of Pseudomonas aeruginosa PAO1 growing in peritoneal chambers in mice.Antimicrob Agents Chemother1989https://conductscience.org/library/papers/2508542PubMed
1952849Failure of beta-lactam antibiotics and marked efficacy of fluoroquinolones in treatment of murine Yersinia pseudotuberculosis infection.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1952849PubMed
1803987Antimicrobial agent therapy for Pseudomonas aeruginosa.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1803987PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/96735

GET https://conductscience.org/api/papers/v1/96735/authors